The analysis of 23 real samples of genomic DNA voluntarily collected from 6 controls and 17 cancer patients revealed that the bioassay can differentiate between the controls having the major allele and the patients which have one or two point mutations in one or two alleles of the IL6 gene. This evidence concerns the gene IL6 and cancer.